Stryker (NYSE:SYK) is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment. Stryker also develops and supports robotic-assisted surgical systems and associated software aimed at improving procedural precision and outcomes.
Founded in 1941 by Dr. Homer Stryker, the company has grown through ongoing product development and strategic acquisitions to expand its technology portfolio and geographic reach. Stryker’s offerings include implants, capital equipment, instruments, disposables and digital solutions, together with training, service and clinical support for healthcare providers. The company serves a global customer base of hospitals, outpatient centers, clinicians and emergency responders and emphasizes research and development, clinical collaborations and post-market support to drive innovation and adoption.
Headquartered in Kalamazoo, Michigan, Stryker operates manufacturing, research and distribution facilities around the world and sells its products in numerous international markets across the Americas, Europe, Asia Pacific and other regions. The company is managed by an executive leadership team and overseen by a board of directors; its operations place ongoing emphasis on regulatory compliance, quality systems, clinical evidence generation and partnerships with healthcare professionals to advance patient care.
